HPV Vaccine Refusal Explored Among Cancer Survivors

MONDAY, Dec. 19, 2022 -- Cancer survivors refusing participation in a trial assessing the safety and immunogenicity of the human papillomavirus (HPV) vaccine do so mainly due to vaccine-related concerns, according to a study published online Dec. 19...